289 related articles for article (PubMed ID: 18435653)
1. Modulation of matrix metalloproteinases by ultraviolet radiation in the canine cornea.
Chandler HL; Kusewitt DF; Colitz CM
Vet Ophthalmol; 2008; 11(3):135-44. PubMed ID: 18435653
[TBL] [Abstract][Full Text] [Related]
2. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the human lens: implications for cortical cataract formation.
Sachdev NH; Di Girolamo N; Nolan TM; McCluskey PJ; Wakefield D; Coroneo MT
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4075-82. PubMed ID: 15505058
[TBL] [Abstract][Full Text] [Related]
4. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
Huh MI; Lee YM; Seo SK; Kang BS; Chang Y; Lee YS; Fini ME; Kang SS; Jung JC
J Cell Biochem; 2007 Aug; 101(5):1222-37. PubMed ID: 17295208
[TBL] [Abstract][Full Text] [Related]
5. Expression of membrane-type matrix metalloproteinases 4, 5, and 6 in mouse corneas infected with P. aeruginosa.
Dong Z; Katar M; Alousi S; Berk RS
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3223-7. PubMed ID: 11726626
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of amniotic membrane in murine herpes stromal keratitis modulates matrix metalloproteinases in the cornea.
Heiligenhaus A; Li HF; Yang Y; Wasmuth S; Steuhl KP; Bauer D
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4079-85. PubMed ID: 16249483
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
Docampo MJ; Cabrera J; Rabanal RM; Bassols A
Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
[TBL] [Abstract][Full Text] [Related]
8. Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves.
Aupperle H; Thielebein J; Kiefer B; März I; Dinges G; Schoon HA; Schubert A
J Comp Pathol; 2009 May; 140(4):271-7. PubMed ID: 19285315
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase 2 and 9 in experimentally wounded canine corneas and spontaneous chronic corneal epithelial defects.
Carter RT; Kambampati R; Murphy CJ; Bentley E
Cornea; 2007 Dec; 26(10):1213-9. PubMed ID: 18043179
[TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility class II expression in the normal canine cornea and in canine chronic superficial keratitis.
Williams DL
Vet Ophthalmol; 2005; 8(6):395-400. PubMed ID: 16359362
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of matrix metalloproteinase concentrations in precorneal tear film from dogs with Pseudomonas aeruginosa-associated keratitis.
Wang L; Pan Q; Xue Q; Cui J; Qi C
Am J Vet Res; 2008 Oct; 69(10):1341-5. PubMed ID: 18828693
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
Rohini G; Murugeswari P; Prajna NV; Lalitha P; Muthukkaruppan V
Cornea; 2007 Feb; 26(2):207-11. PubMed ID: 17251814
[TBL] [Abstract][Full Text] [Related]
13. Identification of ocular matrix metalloproteinases present within the aqueous humor and iridocorneal drainage angle tissue of normal and glaucomatous canine eyes.
Weinstein WL; Dietrich UM; Sapienza JS; Carmichael KP; Moore PA; Krunkosky TM
Vet Ophthalmol; 2007; 10 Suppl 1():108-16. PubMed ID: 17973842
[TBL] [Abstract][Full Text] [Related]
14. Ultraviolet radiation and the role of matrix metalloproteinases in the pathogenesis of ocular surface squamous neoplasia.
Ng J; Coroneo MT; Wakefield D; Di Girolamo N
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5295-306. PubMed ID: 18641285
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases 2 and 9 in experimental corneal injury and fungal keratitis.
Mitchell BM; Wu TG; Chong EM; Pate JC; Wilhelmus KR
Cornea; 2007 Jun; 26(5):589-93. PubMed ID: 17525657
[TBL] [Abstract][Full Text] [Related]
16. Influence of persistent canine distemper virus infection on expression of RECK, matrix-metalloproteinases and their inhibitors in a canine macrophage/monocytic tumour cell line (DH82).
Puff C; Krudewig C; Imbschweiler I; Baumgärtner W; Alldinger S
Vet J; 2009 Oct; 182(1):100-7. PubMed ID: 18684651
[TBL] [Abstract][Full Text] [Related]
17. [Expression of matrix metalloproteinases in experimental herpes simplex virus keratitis].
Yang YN; Bauer D; Li HP; Heiligenhaus A
Zhonghua Yan Ke Za Zhi; 2004 Jun; 40(6):395-9. PubMed ID: 15312605
[TBL] [Abstract][Full Text] [Related]
18. Effect of fluoroquinolones on the expression of matrix metalloproteinase in debrided cornea of rats.
Sharma C; Velpandian T; Baskar Singh S; Ranjan Biswas N; Bihari Vajpayee R; Ghose S
Toxicol Mech Methods; 2011 Jan; 21(1):6-12. PubMed ID: 21058936
[TBL] [Abstract][Full Text] [Related]
19. GSK-3-specific inhibitor-supplemented hESC medium prevents the epithelial-mesenchymal transition process and the up-regulation of matrix metalloproteinases in hESCs cultured in feeder-free conditions.
Ullmann U; Gilles C; De Rycke M; Van de Velde H; Sermon K; Liebaers I
Mol Hum Reprod; 2008 Mar; 14(3):169-79. PubMed ID: 18263607
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-2 and -9 involvement in canine tumors.
Loukopoulos P; Mungall BA; Straw RC; Thornton JR; Robinson WF
Vet Pathol; 2003 Jul; 40(4):382-94. PubMed ID: 12824510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
